RenovoRx, Inc. Research And Development Expense

• RenovoRx, Inc. showed an increase of +4.0% in Research And Development Expense from 2024 to 2025.
• This data is from RenovoRx, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), RenovoRx, Inc.'s Research And Development Expense has grown by 162.7%.
• Historical annual values: Fiscal year 2025: $6.27 million | Fiscal year 2024: $6.03 million | Fiscal year 2023: $5.67 million | Fiscal year 2022: $4.30 million | Fiscal year 2021: $3.04 million | Fiscal year 2020: $2.39 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026